Last reviewed · How we verify
Calcined magnesia — Competitive Intelligence Brief
phase 3
Antacid and osmotic laxative
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Calcined magnesia (Calcined magnesia) — Centro Universitario de Ciencias de la Salud, Mexico. Calcined magnesia (magnesium oxide) acts as an antacid and laxative by neutralizing gastric acid and promoting bowel motility.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Calcined magnesia TARGET | Calcined magnesia | Centro Universitario de Ciencias de la Salud, Mexico | phase 3 | Antacid and osmotic laxative |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antacid and osmotic laxative class)
- Centro Universitario de Ciencias de la Salud, Mexico · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Calcined magnesia CI watch — RSS
- Calcined magnesia CI watch — Atom
- Calcined magnesia CI watch — JSON
- Calcined magnesia alone — RSS
- Whole Antacid and osmotic laxative class — RSS
Cite this brief
Drug Landscape (2026). Calcined magnesia — Competitive Intelligence Brief. https://druglandscape.com/ci/calcined-magnesia. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing